gvtcx

NHS South of England Branded Medicines - Tranche A - Contracts Finder Award Notice

NHS England Published 15 Mar 2019 Contracts Finder

key details

Value£1
Statuscomplete
Category (CPV) 33600000
RegionSouth East, South West, North East, North West, East Midlands, West Midlands, East of England
Deadline15 Apr 2019
Contract start1 Sept 2019
Contract end31 Aug 2021
Procedureopen
SME suitableYes
OCIDocds-b5fd17-8b5e045d-6a03-4c26-b452-fcd5b23d5349

Awards (26)

This procurement was awarded to 26 suppliers. Values shown are per-award; the notice total is £1.

SupplierValueDateStatus
04703428 shared £188,004,961 31 Jul 2019 active
ABBVIE LTD shared £188,004,961 31 Jul 2019 active
ACCORD LIMITED shared £188,004,961 31 Jul 2019 active
ALLERGAN LIMITED shared £188,004,961 31 Jul 2019 active
AMGEN LIMITED shared £188,004,961 31 Jul 2019 active
BIOGEN LTD shared £188,004,961 31 Jul 2019 active
BRISTOL-MYERS SQUIBB PHARMACEUTICALS LIMITED shared £188,004,961 31 Jul 2019 active
CHUGAI PHARMA shared £188,004,961 31 Jul 2019 active
ELI LILLY AND COMPANY LIMITED shared £188,004,961 31 Jul 2019 active
FERRING PHARMACEUTICALS LIMITED shared £188,004,961 31 Jul 2019 active
GILEAD SCIENCES LTD shared £188,004,961 31 Jul 2019 active
IPSEN LIMITED shared £188,004,961 31 Jul 2019 active
JANSSEN-CILAG LIMITED shared £188,004,961 31 Jul 2019 active
MERCK SERONO LIMITED shared £188,004,961 31 Jul 2019 active
MERCK SHARP & DOHME LIMITED shared £188,004,961 31 Jul 2019 active
NAPP PHARMACEUTICALS LIMITED shared £188,004,961 31 Jul 2019 active
NOVO NORDISK LIMITED shared £188,004,961 31 Jul 2019 active
PFIZER LIMITED shared £188,004,961 31 Jul 2019 active
PHARMACOSMOS UK LIMITED shared £188,004,961 31 Jul 2019 active
ROCHE PRODUCTS LIMITED shared £188,004,961 31 Jul 2019 active
SANDOZ LIMITED shared £188,004,961 31 Jul 2019 active
TAKEDA PHARMACEUTICALS EUROPE LIMITED shared £188,004,961 31 Jul 2019 active
TEVA PHARMACEUTICALS LIMITED shared £188,004,961 31 Jul 2019 active
UCB PHARMA LIMITED shared £188,004,961 31 Jul 2019 active
VIFOR LTD shared £188,004,961 31 Jul 2019 active
VIIV HEALTHCARE LIMITED shared £188,004,961 31 Jul 2019 active

description

NHS Framework for the NHS South of England, Branded Medicines - Tranche A, Cytokine Modulators and other monoclonal Antibodies, and Antiretrovirals (Doravirine only) for Midlands & East and North of England.

Offer reference number: CM/PHR/16/5521

CM/PHR/16/5521/01 - NHS Framework for the NHS South of England, Branded Medicines - Tranche A, Period of framework: 1 September 2019 to 31 August 2021 with an option to extend (at the Authority's discretion) for a period or periods up to a total of 24 months

CM/PHR/16/5521/02 - NHS Framework for the NHS South of England, Branded Medicines - Annual Tranche - Cytokine Modulators and other monoclonal antibodies, Period of framework: 1 September 2019 to 31 August 2020 with an option to extend (at the Authority's discretion) for a period or periods up to a total of 12 months

CM/PHR/16/5521/03 - NHS Framework Agreement for Proprietary Pharmaceuticals Interim 2019 - Midlands & East and North of England, Period of framework agreement: Midlands & East 1 September 2019 to 29 February 2020: North of England 1 September 2019 to 28 February 2021

documents

Documents are linked, not mirrored. They are served by the publishing authority and may require registration.

notice history

1 notice published against this procurement.

PublishedTypeRegimeNotice
17 Oct 2019 Award (award) · 4c38ae06-d87a-4e03-a0dd-6a7e67925c1e-320168

more from NHS England

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.